Novel anti-HIV agent enters Phase IIa clinical trial.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use*
D019380:Anti-HIV Agents; C522536:KP 1461; D009705:Nucleosides